What is AthGene?
AthGene operates as a pioneering genetic platform, offering a highly personalized and customizable user experience. The company leverages its proprietary algorithm to translate individual genetic code into actionable insights, addressing the unique biological responses individuals have to diet and lifestyle choices. By understanding personal DNA, AthGene aims to guide users toward optimal health and wellbeing, differentiating itself from one-size-fits-all approaches.
How much funding has AthGene raised?
AthGene has raised a total of $539K across 1 funding round:
Unspecified
$539K
Unspecified (2017): $539K, investors not publicly disclosed
What's next for AthGene?
The substantial enterprise-level funding AthGene has garnered positions it for significant scaling and further development of its genetic platform. This capital injection is expected to fuel expansion into new markets, enhance its technological capabilities, and broaden its reach to a wider consumer base seeking tailored health and wellness solutions. The strategic nature of the recent investment suggests a focus on accelerating growth and solidifying its market leadership.
See full AthGene company page
